AI-Based Early Detection System for Prostate and Bladder Cancer

This trial is establishing and testing an artificial intelligence-based screening system designed to detect prostate and bladder cancer at early stages. Researchers in Beijing want to create a streamlined pathway where men get screened at community clinics, receive detailed diagnosis at hospitals if needed, and access treatment at specialized medical centers. The goal is to catch these cancers earlier, when they're easier to treat and outcomes are better.

Prostate cancer is becoming increasingly common in China and causes more deaths there than in Western countries, partly because China doesn't yet have a well-organized screening system. By developing an artificial intelligence tool to identify cancer risk early, researchers hope to reduce deaths and improve survival rates across the male population.